A4-a6:unk.B3: unk.D4 (experiation date); unk no serial number reported.D6a: unk.H4 (device manufacturing date): no serial number reported.Manufacturer's narrative: a review of the device labeling was completed.Iritis is identified in the labeling as a known adverse event from icl implantation.The dfu states potential adverse events can include iritis and may require secondary surgery.The dfu states, administration and instruction for use: complete removal of the viscoelastic material from the eye must be performed after completion of the surgical procedure and before the eye is closed (without sutures).A dfu caution states: staar surgical evo|evo+ icl and disposable accessories are packaged and sterilized for single use only.Cleaning, reuse and/or resterilization are not applicable to these devices.If one of these devices were reused after cleaning and/or resterilization, it is highly probable that it would be contaminated and the contamination could result in infection and/or inflammation.Toxic anterior segment syndrome (tass) is an acute sterile postoperative inflammation that can occur after uncomplicated or complicated intraocular surgery.While improper sterilization and contamination of surgical instruments remains the most common risk factor associated with tass, ocular viscoelastic, and improper preparation of antibiotics for intracameral injection may also lead to tass.An exact cause could not be determined as the event could be multifactorial in nature including patient and/or procedure related factors.(b)(4).
|